Corteva (NYSE:CTVA) Earns "Outperform" Rating from Royal Bank Of Canada

Key Points

• Royal Bank of Canada reaffirmed its “Outperform” rating on Corteva and set a $103 price target, implying 23.46% upside from the prior close.
• Corteva has a “Moderate Buy” consensus rating from analysts, with 14 Buy ratings and nine Holds and an average price target of $91.50.
• The company recently exceeded quarterly EPS expectations, reporting $2.30 versus the $2.24 consensus, although revenue fell 1.2% year over year to $6.38 billion; institutional investors own 81.54% of the stock.

Corteva (NYSE:CTVA - Get Free Report)'s stock had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada in a research report issued on Wednesday, Benzinga reports. They currently have a $103.00 price target on the stock. Royal Bank Of Canada's price objective would indicate a potential upside of 23.46% from the stock's previous close.

Several other research analysts have also weighed in on the stock. Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an "overweight" rating in a research note on Thursday, May 28th. Oppenheimer raised their target price on shares of Corteva from $89.00 to $95.00 and gave the company an "outperform" rating in a research note on Thursday, July 23rd. Barclays lifted their price target on Corteva from $84.00 to $91.00 and gave the stock an "overweight" rating in a report on Thursday, June 11th. KeyCorp initiated coverage on Corteva in a research note on Thursday, September 10th. They issued a "sector weight" rating on the stock. Finally, JPMorgan Chase & Co. raised their price objective on Corteva from $77.00 to $83.00 and gave the company a "neutral" rating in a research report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Corteva presently has a consensus rating of "Moderate Buy" and a consensus target price of $91.50.

Corteva Trading Up 1.1%

Shares of Corteva stock opened at $83.43 on Wednesday. The stock has a market cap of $55.66 billion, a P/E ratio of 55.25, a P/E/G ratio of 2.53 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva has a 12-month low of $60.53 and a 12-month high of $90.97. The business's 50 day moving average is $83.35 and its 200-day moving average is $81.44.

Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to analysts' expectations of $6.60 billion. During the same period last year, the business earned $2.20 earnings per share. The firm's revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts predict that Corteva will post 3.72 earnings per share for the current fiscal year.

Institutional Trading of Corteva

Several large investors have recently modified their holdings of CTVA. BlackRock Inc. bought a new stake in Corteva during the second quarter worth $4,560,180,000. Norges Bank bought a new position in shares of Corteva in the 4th quarter valued at $504,001,000. Wellington Management Group LLP increased its stake in shares of Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Jupiter Topco LLC acquired a new position in shares of Corteva during the 2nd quarter worth $544,246,000. Finally, Bank of America Corp DE acquired a new position in shares of Corteva during the 2nd quarter worth $484,927,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Spinoff formally approved: Corteva’s board approved the distribution of Vylor, advancing the company’s plan to create two independent, publicly traded businesses. The separation could allow Corteva’s crop-protection operations and Vylor’s seed business to pursue more focused strategies. Corteva Board of Directors Approves Vylor Distribution
• Positive Sentiment: Seed technology offers long-term growth: Vylor said its hybrid wheat platform, marketed as Xpedite, is expected to launch in late 2027. The company forecasts approximately $500 million in North American wheat revenue by 2035 and $1 billion by 2040. Vylor Confirms Breakthrough Wheat Technology Will Launch in 2027
• Positive Sentiment: Expanded soybean strategy: Vylor plans four technology platforms by 2035, including broader-spectrum insect control in Latin America, and expects roughly $500 million of incremental revenue by 2035. The initiatives support the investment case for Corteva’s seed assets ahead of the separation. Vylor to Expand Soybean Leadership
• Neutral Sentiment: Investor Day provided additional detail on the separation, innovation pipeline and long-term strategy, but the supplied update does not include specific new FY 2029 EPS figures. Corteva Analyst/Investor Day Transcript
• Negative Sentiment: Regulatory and litigation uncertainty remains: Several state attorneys general are seeking to block the corporate separation. Corteva rejected their allegations as unfounded, but the dispute could delay the October 1 transaction or increase execution costs. Corteva Rejects State Attorneys General Allegations

About Corteva

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.